4//SEC Filing
Aroesty Jason D 4
Accession 0001237648-20-000071
CIK 0001038133other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 3:56 PM ET
Size
13.4 KB
Accession
0001237648-20-000071
Insider Transaction Report
Form 4
HESKA CORPHSKA
Aroesty Jason D
EVP, International Diagnostics
Transactions
- Sale
Common Stock
2020-11-27$126.68/sh−10,233$1,296,329→ 3,101 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2020-11-27−1,874→ 937 totalExercise: $106.67From: 2018-07-25Exp: 2028-07-24→ Common Stock (1,874 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-27−11,460→ 5,729 totalExercise: $106.67From: 2018-07-25Exp: 2028-07-24→ Common Stock (11,460 underlying) - Exercise/Conversion
Common Stock
2020-11-27$106.67/sh+11,460$1,222,438→ 11,460 total - Exercise/Conversion
Common Stock
2020-11-27$106.67/sh+1,874$199,900→ 13,334 total - Sale
Common Stock
2020-11-27$127.44/sh−3,101$395,188→ 0 total
Footnotes (2)
- [F1]The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.16 to $127.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
- [F2]The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.16 to $127.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
Documents
Issuer
HESKA CORP
CIK 0001038133
Entity typeother
Related Parties
1- filerCIK 0001737532
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 3:56 PM ET
- Size
- 13.4 KB